Development of antidiabetic drugs from benzamide derivatives as glucokinase activator: A computational approach

Hyperglycemia is a condition known for the impairment of insulin secretion and is responsible for diabetes mellitus. Various small molecule inhibitors have been discovered as glucokinase activators. Recent studies on benzamide derivatives showed their importance in the treatment of diabetes as gluco...

Descripción completa

Detalles Bibliográficos
Autor principal: Ali, Amena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280248/
https://www.ncbi.nlm.nih.gov/pubmed/35844378
http://dx.doi.org/10.1016/j.sjbs.2022.01.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280248/
https://www.ncbi.nlm.nih.gov/pubmed/35844378
http://dx.doi.org/10.1016/j.sjbs.2022.01.058

Ejemplares similares